My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Contributor

Location

Published Date

Displaying 3 results for

GO
Search Filters: Christina Severin cancel

Policy Considerations for Reducing Congenital Syphilis

Report,
Population Health and Prevention,
Social and Behavioral Health,
STIs,
Women, Infant, and Family Health,
Infant and Child Health,
Maternal Morbidity and Mortality,
Risk-Appropriate Care,
Policy,
State Health Policy,
JoAnne McClure,
Maggie Davis,
Julia Greenspan,
Christina Severin

This report focuses on promising strategies in four different policy areas to address rising congenital syphilis rates. While no single policy solution will address the structural challenges to diagnosing and treating syphilis among people ...

2023 Legislative Session Update: Part One

Blog,
Health Policy Update,
Policy,
State Health Policy,
Territorial Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Mental Health,
STIs,
HIV,
Substance Misuse,
Opioids,
Tobacco Control,
Environmental Health,
Food and Water Safety,
PFAS,
Florida,
Guam,
Hawaii,
Illinois,
Indiana,
Kentucky,
Mississippi,
New Mexico,
New York,
Oklahoma,
South Dakota,
Utah,
Vermont,
Virginia,
West Virginia,
Beth Giambrone,
Christina Severin,
Parker Beene,
Maggie Davis

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.

Handle with Care: State Newborn Screening Policies

Blog,
Health Policy Update,
Population Health and Prevention,
Women, Infant, and Family Health,
Infant and Child Health,
Policy,
State Health Policy,
Public Health Law,
Arkansas,
California,
Connecticut,
Louisiana,
Maryland,
Massachusetts,
Montana,
New Hampshire,
New Jersey,
New York,
Pennsylvania,
Texas,
Utah,
Wisconsin,
Christina Severin,
Lauren Jones

In the U.S., jurisdictions vary in their newborn screening practices and requirements related to the scope of testing, approach to parental consent, options for blood sample destruction, sample retention periods, and permissible uses of ...